Stoke Therapeutics, Inc. (STOK) Shareholders’ equity 2022–2025
Stoke Therapeutics, Inc. (STOK) shareholders’ equity at each fiscal year-end, per SEC filings.
$352.5MFY2025 · since FY2022: $184.8M → $352.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $352.5M | +53.9% |
| FY2024 | $229.0M | +43.5% |
| FY2023 | $159.6M | -13.7% |
| FY2022 | $184.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice